Read more

May 19, 2022
1 min read
Save

Long-term cardiovascular risk trajectory predicts cognitive decline, dementia

Cumulative cardiovascular risk is a significant factor in determining the risk for cognitive decline and dementia, according to a study published in Neurology.

“While vascular dementia de facto results from vascular injury, recent evidence has also implicated the role of cardiovascular factors in the progression of [Alzheimer’s disease],” Bryn Farnsworth von Cederwald, PhD, of the department of integrative medical biology at Umea University in Sweden, and colleagues wrote. “Notably, approximately 80% of patients diagnosed with AD exhibit vascular pathology when inspected at autopsy.”

Man trying to think
Source: Adobe Stock.

Researchers sought to examine whether cardiovascular risk trajectory influences subsequent dementia and memory decline risk and hypothesized that cumulative, long-term cardiovascular risk — determined by the Framingham Risk Score (FRS) — would negatively affect cognitive outcomes.

They examined a sample of 1,244 initially healthy participants from the longitudinal, population based Betula study who were recruited at two separate time points (1988-1990 and 1993-1995). Researchers measured cardiovascular disease risk via the FRS, as well as performance of episodic memory and dementia status, at 5-year intervals across 20 to 25 years.

Results showed that cardiovascular risk increased moderately over time in 60% of the sample population, with observations of an accelerated increase in 18% of participants and minimal change in 22%. An accelerated cardiovascular risk trajectory predicted an increased risk of developing AD dementia [average RR, 3.3-5.7; 95% CI, 2.6-17.5 at the second time point (T2) and 1.9-6.7 at the fifth time point (T5)] or vascular dementia (aRR, 3.3-4.1; 95% CI, 1.1-16.6 at T2 and 1.5-7.6 at T5) and was associated with an increased risk for memory decline (aRR, 1.4-1.2; 95% CI, 1-1.9 at T2 and 1-1.5 at T5).

“Future research may benefit from further exploring how longitudinal [cardiovascular disease] risk affects the accumulation of neuropathology,” von Cederwald and colleagues wrote.